四黄水蜜外敷治疗痛风发作的疗效观察

Therapeutic effect of Sihuang Shuimi on gout attack

ES评分 0

DOI 10.12208/j. jmnm.202200074
刊名
Journal of Modern Nursing MedicineJPCNS
年,卷(期) 2022, 1(2)
作者
作者单位

广东省梅州市梅县区中医医院 广东梅州 ;

摘要
目的:分析痛风发作用四黄水蜜外敷疗法的价值。方法:对2021 年4 月-2022 年4 月本科接 诊痛风发作病人(n=74)进行随机分组,试验和对照组各 37 人,前者采取四黄水蜜外敷疗法,后者行常规 治疗。对比不良反应等指标。结果:关节总有效率,试验组的数据97.3%,和对照组81.08%相比更高(P< 0.05)。关于不良反应,试验组的发生率 0,和对照组 16.22%相比更低(P<0.05)。关于肿瘤坏死因子-α, 疗程结束之时:试验组的数据(5.31±1.04)ng/ml,和对照组(19.37±4.68)ng/ml 相比更低(P<0.05)。关 于 sf-36 评分,疗程结束之时:试验组的数据(88.51±3.64)分,和对照组(79.22±4.73)分相比更高(P< 0.05)。结论:痛风发作用四黄水蜜外敷疗法,效果显著,病人的预后也更好,不良反应更少,炎性因子改 善更加明显。
Abstract
Objective: To analyze the value of external application of Sihuang water honey in the treatment of gout. Methods: Patients with gout attack (n=74) were randomly divided into experimental group and control group from April 2021 to April 2022. The former was treated with external application of Sihuang water honey, and the latter was treated with routine treatment. Adverse reactions and other indicators were compared. Results: the total effective rate of the test group was 97.3%, which was higher than that of the control group (81.08%) (P < 0.05). As for adverse reactions, the incidence of the test group was 0, lower than that of the control group (16.22%) (P < 0.05). About tumor necrosis factor- α, At the end of the course of treatment: the data of the experimental group was (5.31 ± 1.04) ng/ml, which was lower than that of the control group (19.37 ± 4.68) ng/ml (P < 0.05). In terms of SF-36 score, at the end of treatment, the score of the experimental group (88.51±3.64) was higher than that of the control group (79.22±4.73) (P < 0.05). Conclusion: The effect of gout is remarkable, the prognosis of patients is better, the adverse reaction is less, and the improvement of inflammatory factors is more obvious.
关键词
痛风发作;价值;四黄水蜜;不良反应
KeyWord
Gout attack; Value; Four yellow water honey; Adverse reactions
基金项目
页码 26-28
  • 参考文献
  • 相关文献
  • 引用本文

王伟平*. 四黄水蜜外敷治疗痛风发作的疗效观察 [J]. 现代护理医学杂志. 2022; 1; (2). 26 - 28.

  • 文献评论

相关学者

相关机构